Skip to content

Patch testing with Indian standard series and cosmetic series in eyelid eczema patients visiting a tertiary care hospital in eastern India

Patch testing with Indian standard series and cosmetic series in eyelid eczema patients visiting a tertiary care hospital in eastern India- a cross-sectional study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/10/076090
Enrollment
80
Registered
2024-10-30
Start date
Unknown
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L232- Allergic contact dermatitis due tocosmetics

Interventions

Intervention1: Patch test: patch testing with Indian standard series and Cosmetic series of 52 allergens put over upper back of patient, single application on first day. Patch test removal and interpr

Sponsors

Institute of Medical Science(IMS) and SUM Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with suspected cases of eyelid dermatitis coming to out patient department and consenting for patch test age more than 18yrs

Exclusion criteria

Exclusion criteria: 1. History of connective skin disease 2. History of immunocompromised disorders 3. History of auto immune diseases 4. Any current acute severe skin diseases 5. Patients on oral corticosteroids more than or equal to 15mg equivalent dose of prednisolone in last 14 days of patch testing/ applying potent topical steroids over patch test site 6. History of drug rashes. 7. History of Type 1 diabetes mellitus, hypothyroidism and other endocrine abnormalities 8. History of tendency for vitiligo and keloids

Design outcomes

Primary

MeasureTime frame
patch test positive to any of 52 allergensTimepoint: first reading after 48 hours, second reading after 72 hours, third reading after 96 hours

Secondary

MeasureTime frame
patch test negative to all allergens after 48 hoursTimepoint: first reading after 48 hours, second reading after 72 hours, third reading after 96 hours

Countries

India

Contacts

Public ContactShatabdee Sahoo

IMS and SUM Hospital

shatabdeesssahoo@gmail.com9178292407

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026